VANCOUVER, British Columbia--(BUSINESS WIRE)--March 21, 2006--PhytoMedical to Expand Scientific Team to Accelerate Pace and Scope of Research; Compounds That Improve Insulin Sensitivity Could Also Improve Alzheimer’s Disease. PhytoMedical Technologies, Inc. (OTCBB:PYTO) (FWB:ET6) today announced that it recently has extended the term and scope of its three-way Cooperative Research and Development Agreement (CRADA) with Iowa State University (ISU) and the USDA’s Agricultural Research Service (ARS) so as to allow the Company to accelerate its research plans for the development of a new compound for the treatment of type-2 diabetes.
